What is the fair value of Pulmatrix Inc (NASDAQ-PULM) stock?

The current fair value estimate for Pulmatrix Inc (NASDAQ-PULM) is $1.56. This implies an estimated downside of 7.2% versus the current market price.

Is Pulmatrix Inc (NASDAQ-PULM) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 7.2% versus the current market price.

How is the financial health of Pulmatrix Inc?

The current financial health read for Pulmatrix Inc (NASDAQ-PULM) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Pulmatrix Inc's next earnings date?

The next earnings date currently listed for Pulmatrix Inc (NASDAQ-PULM) is August 12, 2026.

Does Pulmatrix Inc (NASDAQ-PULM) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for Pulmatrix Inc (NASDAQ-PULM)?

The current P/E ratio listed for Pulmatrix Inc (NASDAQ-PULM) is -1.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Pulmatrix Inc?

The current market capitalization listed for Pulmatrix Inc is 6.136 M.

What is the enterprise value of Pulmatrix Inc?

The current enterprise value listed for Pulmatrix Inc is 3.762 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Pulmatrix Inc?

The ticker symbol for Pulmatrix Inc is NASDAQ-PULM, and the stock is listed on NASDAQ.

Where is Pulmatrix Inc (NASDAQ-PULM) listed?

Pulmatrix Inc (NASDAQ-PULM) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Pulmatrix Inc?

The current debt-to-total-capital ratio listed for Pulmatrix Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Pulmatrix Inc?

The free float listed for Pulmatrix Inc is 100.0%. Free float helps investors understand how much of the share base is available for public trading.

Pulmatrix Inc (PULM) Fair Value & Stock Analysis

Q: What is the analyst price target for NASDAQ-PULM stock?

An analyst price target for Pulmatrix Inc (NASDAQ-PULM) is not currently available in the latest data file.

Pulmatrix Inc (PULM)

Pulmatrix Inc (NASDAQ-PULM) is a Healthcare company whose common stock is traded on NASDAQ under the security context of common equity. The company is associated with pharmaceutical development focused on inhaled medicines and related delivery technology for respiratory and other medical uses. Its work centers on drug formulation and product candidates intended for treatment areas such as airway disease, migraine, and other conditions that may be addressed through inhalation-based delivery. As a listed company security, PULM represents equity exposure to Pulmatrix Inc rather than a fund, debt instrument, or other special security type.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-PULM	$1.56	-7.2% Downside	Fair	—	—	—	Fair	—	—	—	0.0%	August 12, 2026	-1.4x	2.3x	—	6.136 M	3.762 M	0.0%	100.0%	-92.9	—	103.6%